Targeted Therapy and Immunotherapy Response Assessment with F-18 Fluorothymidine Positron-Emission Tomography/Magnetic Resonance Imaging in Melanoma Brain Metastasis: A Pilot Study

Targeted Therapy and Immunotherapy Response Assessment with F-18 Fluorothymidine Positron-Emission Tomography/Magnetic Resonance Imaging in Melanoma Brain Metastasis: A Pilot Study

IntroductionThis pilot study aimed at exploring the utility of the proliferation tracer F-18 fluorothymidine (FLT) and positron-emission tomography (PET)/magnetic resonance imaging (MRI) (FLT–PET/MRI) for early treatment monitoring in patients with melanoma brain metastasis (MBM) who undergo targete...

Full description

Bibliographic Details
Main Authors: Nghi C. Nguyen, Melissa K. Yee, Abuzar M. Tuchayi, John M. Kirkwood, Hussein Tawbi, James M. Mountz
Format: Article
Language:English
Published: Frontiers Media S.A. 2018-02-01
Series:Frontiers in Oncology
Subjects:
F-18 fluorothymidine–
PET/MRI
melanoma brain metastasis
targeted antitumor therapy
immunotherapy
early response evaluation
Online Access:http://journal.frontiersin.org/article/10.3389/fonc.2018.00018/full

Internet

http://journal.frontiersin.org/article/10.3389/fonc.2018.00018/full

Similar Items